Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis

Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis

Abstract Tacrolimus interacts with letermovir and azole antifungals, whereas letermovir has nonuniform effects on the pharmacokinetics of azole antifungals. We retrospectively investigated the interaction of tacrolimus (continuous infusion) with letermovir considering co‐administered azole antifunga...

Full description

Bibliographic Details
Main Authors:	Yuri Shinogi, Toshinori Hirai, Miki Ishibashi, Kazuko Ino, Isao Tawara, Takuya Iwamoto
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	Pharmacology Research & Perspectives
Subjects:	azole antifungals drug‐drug interaction hematopoietic stem cell transplantation letermovir tacrolimus
Online Access:	https://doi.org/10.1002/prp2.1120

Similar Items

Drug–drug interactions between letermovir and tacrolimus in Japanese renal transplant recipients simulated using a physiologically based pharmacokinetic model
by: Takumi Maruyama, et al.
Published: (2024-10-01)

LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?
by: Fabian Herrera
Published: (2024-04-01)

Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir
by: Jocelyne Piret, et al.
Published: (2024-01-01)

The Synergistic Effect of Tacrolimus (FK506) or Everolimus and Azoles Against Scedosporium and Lomentospora Species In Vivo and In Vitro
by: Zikuo Wang, et al.
Published: (2022-04-01)

In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation
by: Jochen J Frietsch, et al.
Published: (2019-01-01)

Current Perspectives on Letermovir and Maribavir for the Management of Cytomegalovirus Infection in Solid Organ Transplant Recipients
by: Razonable RR
Published: (2024-09-01)

New Antifungal Agents with Azole Moieties
by: Melissa Martins Teixeira, et al.
Published: (2022-11-01)

Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience
by: Jessica Gill, et al.
Published: (2023-04-01)

Real-Life Data on the Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: A Single-Center Analysis
by: Martyna Wlodarczyk, et al.
Published: (2024-03-01)

Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study
by: Léna Royston, et al.
Published: (2021-04-01)

Letermovir Effectively Prevents Cytomegalovirus Infection in Patients with Aplastic Anemia After Hematopoietic Stem Cell Transplantation: A Real-World Retrospective Cohort Study
by: Yuling Zhang, et al.
Published: (2024-01-01)

Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant Patients with Valganciclovir-Induced Leukopenia
by: Arindam Singha, et al.
Published: (2021-04-01)

Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics
by: Haruno Oku, BS, et al.
Published: (2025-01-01)

Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center review
by: Alyssa K. Mezochow, MD, MSc, et al.
Published: (2024-11-01)

Review of Pharmacologic Considerations in the Use of Azole Antifungals in Lung Transplant Recipients
by: Megan E. Klatt, et al.
Published: (2021-01-01)

Assessment of UL56 Mutations before Letermovir Therapy in Refractory Cytomegalovirus Transplant Recipients
by: Marta Santos Bravo, et al.
Published: (2022-04-01)

Elevation of tacrolimus concentration after administration of methotrexate for treatment of graft-versus-host disease in pediatric patients received allogeneic hematopoietic stem cell transplantation
by: Chiaki Inoue, et al.
Published: (2023-12-01)

Suppression of CMV Infection with Letermovir in a Kidney Transplant Patient
by: Uta Köpf, et al.
Published: (2020-04-01)

Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)

Real-life experience in two cases of secondary prophylaxis with letermovir for CMV infection in solid organ transplantation
by: Ana-Belén Pérez, et al.
Published: (2023-12-01)

Assessing drug-drug interactions of Tacrolimus with Fluconazole and/or Verapamil and developing the predictive model for Tacrolimus concentrations in kidney transplant recipients
by: Mingkwan Na Takuathung, et al.
Published: (2025-06-01)

Approaches for identifying and measuring heteroresistance in azole-susceptible Candida isolates
by: Cécile Gautier, et al.
Published: (2024-04-01)

Small molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates
by: Philip E. Alabi, et al.
Published: (2023-08-01)

QTc Interval Prolongation as an Adverse Event of Azole Antifungal Drugs: Case Report and Literature Review
by: Shiori Kitaya, et al.
Published: (2024-08-01)

Aneuploidy Formation in the Filamentous Fungus Aspergillus flavus in Response to Azole Stress
by: Omer Barda, et al.
Published: (2023-08-01)

Drug-drug interactions of tacrolimus
by: Rančić Nemanja K., et al.
Published: (2015-01-01)

Stability Tests and Analytical Methods of Tacrolimus: A Review
by: Sara Sajjadi, et al.
Published: (2022-12-01)

The Hsp90 co-chaperones Sti1, Aha1, and P23 regulate adaptive responses to antifungal azoles
by: Xiaokui Gu, et al.
Published: (2016-10-01)

Relationship between 2-Hour Tacrolimus Concentrations and Clinical Outcomes in Long Term Kidney Transplantation
by: Jeffrey Yin, et al.
Published: (2020-04-01)

Tacrolimus: Physicochemical stability challenges, analytical methods, and new formulations
by: Sara Sajjadi, et al.
Published: (2024-12-01)

(Mechano)chemical modification of polyvinyl chloride with azole-based drugs
by: Eman S. A. Al-Sammarraie, et al.
Published: (2024-05-01)

Spectrum of activity and mechanisms of azole–bisphosphonate synergy in pathogenic Candida
by: Aidan Kane, et al.
Published: (2024-06-01)

Formulation and development of Tacrolimus nanosponges-loaded hydrogel for the treatment of atopic dermatitis
by: Borse Janhavi D, et al.
Published: (2024-06-01)

Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus
by: Natalia Riva, et al.
Published: (2017-03-01)

The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study
by: Yi-Chang Zhao, et al.
Published: (2022-12-01)

Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC‐MS/MS
by: Mengming Xia, et al.
Published: (2023-11-01)

Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis
by: Naoki Yoshikawa, et al.
Published: (2025-01-01)

Detecting Azole-Antifungal Resistance in <i>Aspergillus fumigatus</i> by Pyrosequencing
by: Mireille H. van der Torre, et al.
Published: (2020-01-01)

Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient
by: Robert D. Maynard, et al.
Published: (2023-08-01)

Resurgence and Repurposing of Antifungal Azoles by Transition Metal Coordination for Drug Discovery
by: Youri Cortat, et al.
Published: (2023-09-01)